News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Katsuaki Maehara: Summary of Major Clinical Trials of ICI’s in Early Stage NSCLC
Katsuaki Maehara/X
Oct 11, 2024, 15:17

Katsuaki Maehara: Summary of Major Clinical Trials of ICI’s in Early Stage NSCLC

Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:

”Summary of Major Clinical Trials of Immune Checkpoint Inhibitors (ICI’s) in Early Stage NSCLC. As of September 2024.

Study design.

Katsuaki Maehara

Key Clinical Data.”

Katsuaki Maehara

Source: Katsuaki Maehara/X

cancer clinical trial Katsuaki Maehara Lung cancer NSCLC OncoDaily Oncology
Special Coverage
Insight
Oct 31, 2024, 10:10
Evaluating the Efficacy of Scalp Cooling on Hair Loss in Patients with Metastatic Breast Cancer: A Phase II Clinical Trial
Blog
Oct 31, 2024, 10:08
Gustavo Viani: High single dose SRS is promising in oligometastatic cancer
Blog
Oct 31, 2024, 09:58
The digital future of cancer care featuring Konrad Korbiński at European Cancer Summit - ECO
Drugs
Oct 31, 2024, 09:57
£3m for world-first trial to revolutionise brain cancer treatment - Cancer Research UK
Blog
Oct 31, 2024, 09:24
Amol Akhade's two cents to Oncology colleagues from India
Blog
Oct 31, 2024, 09:13
Stella Arakelya: Benefits of Holistic Assessment-Based Interventions
Blog
Oct 31, 2024, 09:08
Help give kids with cancer a lifetime they deserve - St. Baldrick's Foundation
Insight
Oct 31, 2024, 09:03
Jarushka Naidoo: Maintenance Pembrolizumab with or without Olaparib for Advanced Squamous NSCLC
Insight
Oct 31, 2024, 08:59
Self-directed online psychosocial intervention for women with metastatic breast cancer - MASCC
Insight
Oct 31, 2024, 08:50
Terence Rabbitts was Elected Honorary Fellow of the Royal College of Physicians
Blog
Oct 31, 2024, 08:46
Rewriting Cancer: Pairing experience with expertise - UICC
Blog
Oct 31, 2024, 08:36
2024 Hamburg Awardees for Advances in Biomedical Research and Clinical Medicine - Dana-Farber Cancer Institute